The primary objective of this proposal is to investigate the mechanisms of host defense that are important for recovery from acute viral infections of the CNS, using SIN encephalitis as a model system. This investigation will provide new insights into virus-host interactions and will thereby provide a biologic framework for the development of new therapeutic antiviral strategies. This proposal will focus on understanding the mechanisms by which MAbs to the SIN E2 envelope glycoprotein restrict SIN gene expression in neurons. Based on preliminary findings demonstrating that the E2 envelope glycoprotein upregulates gene expression in neuroblastoma cells and that anti-E2 MAbs that restrict SIN replication enter virally infected neurons, this research proposal will investigate two principal hypotheses: (1) E2 regulates SIN gene expression and anti-E2 MAbs inhibit SIN replication by altering this regulatory effect; and (2) anti-E2 MAbs act intracellulary to inhibit SIN replication. To investigate the first hypothesis, this proposal will analyze (1) the effects of mutations at amino acid position 55 on the regulation of SIN gene expression in neurons and nonneuronal cells; (2) the role of the transmembrane and cytoplasmic domains of E2 in the regulation of SIN gene expression; (3) the effects of anti-E2 MAbs on E2-mediated upregulation of SIN gene expression; and (4) the role of the cytoplasmic domain of E2 in anti-E2 MAb-mediated inhibition of SIN gene expression. To investigate the second hypothesis, recombinant SIN/immunoglobulin (Ig) gene chimeras will be engineered to express intracellular anti-E2 MAbs in different cellular compartments and the effects of expression of anti-E2 MAbs in different neuronal compartments on SIN replication will be determined.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08AI001217-01
Application #
2057370
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Project Start
1993-12-01
Project End
1996-11-30
Budget Start
1993-12-01
Budget End
1994-11-30
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Hardwick, J M; Levine, B (2000) Sindbis virus vector system for functional analysis of apoptosis regulators. Methods Enzymol 322:492-508
Liang, X H; Goldman, J E; Jiang, H H et al. (1999) Resistance of interleukin-1beta-deficient mice to fatal Sindbis virus encephalitis. J Virol 73:2563-7
Liang, X H; Kleeman, L K; Jiang, H H et al. (1998) Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 72:8586-96
Joe, A K; Foo, H H; Kleeman, L et al. (1998) The transmembrane domains of Sindbis virus envelope glycoproteins induce cell death. J Virol 72:3935-43
Liang, X H; Jiang, H H; Levine, B (1997) Expression of a biologically active antiviral antibody using a sindbis virus vector system. Mol Immunol 34:907-17
Joe, A K; Ferrari, G; Jiang, H H et al. (1996) Dominant inhibitory Ras delays Sindbis virus-induced apoptosis in neuronal cells. J Virol 70:7744-51
Levine, B; Jiang, H H; Kleeman, L et al. (1996) Effect of E2 envelope glycoprotein cytoplasmic domain mutations on Sindbis virus pathogenesis. J Virol 70:1255-60
Shorr, R I; Longo, W L; Oberley, T D et al. (1987) Cytomegalovirus-associated tubulointerstitial nephritis in an allogeneic bone marrow transplant recipient. Ann Intern Med 107:351-2